MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Facial Blendshape Index(FBI) for Quantification of Hypomimia on Parkinson´s Disease

    B. Koyak, T. Menzel, M. Botsch, A. Spottke, M. Reuter, U. Wüllner, NA. Aziz (Dortmund, Germany)

    Objective: To evaluate the validity of ExpressionTracker, an app generating personalized facial blendshapes, for objective quantification of hypomimia in patients with Parkinson’s disease (PD) [1].…
  • 2025 International Congress

    Chronic DBS Stimulation’s effects after 1-hour off stimulation

    M. Varga, Y. Zhao, S. Santacruz (Austin, USA)

    Objective: This study investigates the changes in local field potential (LFP) activity during chronic deep brain stimulation (DBS) in patients with Parkinson's disease (PD) during…
  • 2025 International Congress

    The East London Parkinson Disease Project: Higher Immune Activation found in Patients with Parkinson’s Disease Dementia from a Diverse Population

    A. Zirra, KC. Dey, E. Camboe, E. Bhadra, B. Huxford, R. Laban, N. Donkor, F. Nice, S. Valle Thomas, A. Gaspariunas, L. Mitchell, DA. Gallagher, C. Budu, C. Simonet, T. Boyle, AJ. Lees, D. Yadin, J. Dias, O. Cavlan, CR. Marshall, MT. Perinan, AJ. Noyce (London, United Kingdom)

    Objective: The scope of this work was to characterise the B-cell receptor repertoire of patients with Parkinson’s disease with dementia (PDD), cognitively resilient (PDR) and…
  • 2025 International Congress

    Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease

    P. Antenucci, M. Sensi, V. Resta, L. Spanedda, D. Zecchinato, G. Linzalone, A. Gozzi, L. Zerbinati (Ferrara, Italy)

    Objective: To assess and compare personality profiles and psychiatric symptoms in de-novo clinically-established body-first and brain-first PD. Background: Body-first and brain-first have recently been proposed…
  • 2025 International Congress

    Cognitive Biases in Movement Disorders: Implications for Clinical Decision-Making and Patient Perception of Symptoms

    N. Choudhury, D. Buonadonna, B. Carr (Gainesvile, USA)

    Objective: To explore how cognitive biases affect decision-making in patients with movement disorders, including misjudgments in symptom perception, risk-taking in treatment decisions and adherence to…
  • 2025 International Congress

    Deep Brain Stimulation Increases Motivation to Obtain Larger Rewards in Parkinson’s Disease

    S. Brener, E. Pegolo, A. Hahn, J. Suh, M. Scherbakova, K. Balagula, P. Lockwood, M. Apps, S. Little (Birmingham, United Kingdom)

    Objective: To assess the effects of deep brain stimulation (DBS) on effort and reward processing for self-benefitting and prosocial behavior in people with Parkinson’s Disease…
  • 2025 International Congress

    Retrospective Analysis of the Neuropsychological Profiles of Parkinson’s Disease Patients Selected for Deep Brain Stimulation Surgery in Hawaii.

    E. Krening, A. Ford, M. Bruno, T. Umaki (Honolulu, USA)

    Objective: To investigate the neuropsychological profiles of White, Japanese, and other Asian American or Pacific Islander (OAAPI) patients with Parkinson’s disease (PD) identified as candidates…
  • 2025 International Congress

    Exploratory Longitudinal Analysis of Lifestyle and Parkinson’s Disease Symptoms

    N. Meier, O. Di Martino, I. Chaturvedi (Irvine, USA)

    Objective: This study is an exploratory longitudinal analysis of lifestyle factors and Parkinson’s Disease (PD) symptoms that may inform targeted research into specific lifestyle interventions…
  • 2025 International Congress

    Impact of Skin Biopsy Detection of Phosphorylated Alpha-Synuclein and its Distribution Patterns on the Diagnosis of Synucleinopathies

    M. Chen, M. Christie (Houston, USA)

    Objective: To assess how skin biopsy detection of phosphorylated alpha-synuclein (P-SYN) and its distribution pattern impact the diagnosis of synucleinopathies, such as Parkinson’s disease (PD),…
  • 2025 International Congress

    Turkish Validity and Reliability Study of the Gastrointestinal Dysfunction Scale for Parkinson’s Disease

    S. Irmak, H. Omercikoglu, D. Gunal (İstanbul, Turkey)

    Objective: The aim of this study is to make a Turkish adaptation of the "Gastrointestinal Dysfunction Scale for PD (GIDS-PD)"and detect gastrointestinal symptoms at an…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley